Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jacobson Mark L.
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pizzie Nick
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer TABUTEAU HERRIOT
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahony Susan
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murdock Hunter R.
Axsome Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(4.9%),Peter Harwin(4.9%), etc.
Axsome Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.5%),Roderick Wong, M.D.(9.5%)
Axsome Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.81%)
Axsome Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.8%)
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahony Susan
Axsome Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Mahony Susan
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coleman Mark
Axsome Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Fairmount Funds Management LLC(5.0%),Peter Harwin(5.0%), etc.
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Saad Mark E
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JEFFS ROGER
Axsome Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coleman Mark
No Data